|1.||Fujii, Yoshitaka: 29 articles (12/2011 - 01/2002)|
|2.||Xia, Zhengyuan: 13 articles (01/2015 - 01/2003)|
|3.||Shingu, Koh: 11 articles (07/2015 - 01/2002)|
|4.||Saito, Shigeru: 11 articles (06/2015 - 05/2002)|
|5.||Sessler, Daniel I: 9 articles (03/2015 - 01/2005)|
|6.||Fujii, Y: 9 articles (07/2011 - 06/2000)|
|7.||Inada, Takefumi: 8 articles (07/2015 - 01/2007)|
|8.||Irwin, Michael G: 8 articles (01/2015 - 09/2005)|
|9.||Brown, Emery N: 8 articles (12/2014 - 01/2009)|
|10.||Laureys, Steven: 8 articles (01/2014 - 11/2010)|
12/01/2009 - "Our objective in this randomized, double-blind, placebo-controlled trial was to determine whether a single IV dose of propofol 2.4 mg/kg results in clinically significant reduction in disability or pain in CDH for the next 30 days. "
04/01/2014 - "There was a significant reduction in propofol induced pain score P = 0.0275 and insignificant hemodynamic changes. "
11/01/2011 - "To compare the clinical efficacy of a rapid injection of propofol in regard to pain and ability to facilitate Laryngeal Mask Airway (LMA) insertion. "
03/01/2000 - "The intensity of injection pain was significantly greater for pure propofol than the others while it was not significantly different among the other groups in comparison. "
09/01/1996 - "Propofol at the two higher doses during part of the first immersion produced a significant reduction (p < 0.05) in pain intensity and bothersomeness ratings. "
|2.||Postoperative Nausea and Vomiting (PONV)
06/01/1999 - "Propofol is effective in managing PONV with shorter PACU stay and great degree of patient satisfaction. "
11/01/1996 - "Propofol used only as an induction agent or for induction and at the end of surgery were not as protective against postoperative nausea and vomiting."
06/01/1999 - "This study determines the efficacy of small doses of propofol administered by patient-controlled device for the treatment of PONV. "
08/01/1998 - "Lack of efficacy of propofol in the treatment of early postoperative nausea and vomiting."
07/01/2013 - "The study found that the PONV was significantly reduced in the patient with propofol, no hemodynamic derangements were noted in the postoperative period."
04/01/1997 - "To investigate the efficacy of a subhypnotic dose of propofol to treat vomiting in children after adenotonsillectomy. "
08/01/2011 - "The intravenous anesthetic propofol has a number of well-known nonanesthetic effects, including anti-oxidation and anti-emesis. "
08/01/2010 - "There were no reported incidents of aspiration or emesis during sedation and there were no deaths associated with procedural propofol sedation. "
01/01/2009 - "The 0.257 absolute risk reduction of vomiting with the addition of propofol represents a number needed to treat of 3.87, and a risk ratio of 0.51 (95% CI 0.32 to 0.79). "
10/01/2007 - "To evaluate the rate of adverse respiratory events and vomiting among ED patients undergoing procedural sedation with propofol. "
04/01/1999 - "We observed that propofol was very effective for the refractory general convulsion after surgical operation of cerebral aneurysmal clipping in two patients. "
03/01/2008 - "The present results showed that there was significant reduction in the time required for onset of seizure in propofol treated groups following PTZ treatment. "
09/01/2014 - "Herein, the author reviews the extensive literature for propofol in ECT, focusing on 5 outcome measures: seizure duration, hemodynamics, postanesthesia recovery, cognitive adverse effects, and therapeutic efficacy. "
12/01/2004 - "Propofol proved to be effective in preventing agitation when used as induction agent or when administered at seizure end. "
08/01/1992 - "The greater efficacy of propofol against PTZ convulsions may be a reflection of the opposite action of the two drugs on neural membrane conductance: PTZ induces paroxysmal neural discharge by enhancing membrane conductance while propofol appears to decrease membrane conductance, thus suppressing paroxysmal discharge. "
09/01/2003 - "Moreover, propofol at a subhypnotic dose is effective in the prevention of severe nausea."
03/01/2014 - "The incidence of nausea significantly lower in the propofol 0.5 and propofol 1.0 groups than in the control group (12.1 vs 14.7 vs 40%). "
11/01/2003 - "The propofol infusion group experienced significantly more nausea in the recovery room (p = 0.002), nausea at the time of discharge (p = 0.009), and nausea the evening after the operation (p = 0.013). "
03/01/2001 - "Nausea was less frequent after propofol (16% vs. 48%, P<0.05). "
05/01/1999 - "One patient (3%) experienced nausea prior to discharge in the propofol-N2O group, and two patients (6%) experienced nausea at home in the propofol alone group. "